Printer Friendly

'Boob ops put before life drug' FUNDING.

A KIDNEY cancer expert has blasted health chiefs for refusing patients a breakthrough drug while allowing big-breasted women to have expensive reduction surgery.

Sufferers across the country are unable to get new wonder treatment Sutent.

Despite research that it can extend life by two years or more, primary care trusts say it is not proven and too expensive at pounds 3,000 a month.

Islington in North London is one of many PCTs that put breast reduction patients before such cancer cases.

It is "following guidance" rom drug body Nice which will not rule on Sutent and another drug Nexavar until next year.

But Prof Jonathan Waxman, of London's Hammersmith Hospital, said: "It seems hard to believe that cosmetic ops get priority over cancer."
COPYRIGHT 2008 MGN LTD
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Mirror (London, England)
Date:Jun 9, 2008
Words:124
Previous Article:MUM SUES POLICE; ANOTHER DAY ANOTHER STABBING.
Next Article:Snatched BBC man shot dead; AFGHANISTAN.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters